Pharmacodynamics of ticagrelor vs prasugrel in STEMI patients

Trial Profile

Pharmacodynamics of ticagrelor vs prasugrel in STEMI patients

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2013

At a glance

  • Drugs Ticagrelor (Primary) ; Prasugrel
  • Indications Myocardial infarction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Nov 2013 New trial record
    • 04 Sep 2013 Results (n=92) presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top